Literature DB >> 15604363

Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Atsunori Fukuhara1, Morihiro Matsuda, Masako Nishizawa, Katsumori Segawa, Masaki Tanaka, Kae Kishimoto, Yasushi Matsuki, Mirei Murakami, Tomoko Ichisaka, Hiroko Murakami, Eijiro Watanabe, Toshiyuki Takagi, Megumi Akiyoshi, Tsuguteru Ohtsubo, Shinji Kihara, Shizuya Yamashita, Makoto Makishima, Tohru Funahashi, Shinya Yamanaka, Ryuji Hiramatsu, Yuji Matsuzawa, Iichiro Shimomura.   

Abstract

Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre-B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604363     DOI: 10.1126/science.1097243

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  450 in total

1.  Mechanistic insights into the link between visfatin gene C-1535T polymorphism and coronary artery disease: an in vitro study.

Authors:  Yong-Sheng Wang; Wei Gao; Hong-Fen Li; Ze-Mu Wang; Jun Zhu; Huan Zhao; Jian-Jun Yan; En-Zhi Jia; Zhi-Jian Yang; Lian-Sheng Wang
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

Review 3.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

4.  Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin.

Authors:  Min Xia; Chun Zhang; Krishna M Boini; Audrey M Thacker; Pin-Lan Li
Journal:  Cardiovasc Res       Date:  2010-09-07       Impact factor: 10.787

Review 5.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 6.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

7.  Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease.

Authors:  Qingxia Kong; Min Xia; Ruqing Liang; Lei Li; Xu Cu; Zhuoxiang Sun; Junli Hu
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

8.  Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

9.  Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

10.  Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression.

Authors:  Qiang Wan; Xiaobing Cui; Jiman Shao; Fenghua Zhou; Yuhua Jia; Xuegang Sun; Xiaoshan Zhao; Yuyao Chen; Jianxin Diao; Lei Zhang
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.